<DOC>
	<DOCNO>NCT01243996</DOCNO>
	<brief_summary>The investigator hypothesize early treatment PDA ibuprofen dose high actually recommend might increase closure rate preterm infant gestational age &lt; 29 week without increase occurrence associate adverse effect . To assess hypothesis investigator plan multicenter randomize control study compare effectiveness current ibuprofen regimen high-dose regimen close PDA .</brief_summary>
	<brief_title>High-dose Ibuprofen Patent Ductus Arteriosus ( PDA ) Preterm Infant</brief_title>
	<detailed_description>The patency ductus arteriosus ( PDA ) frequent complication preterm infant suffer respiratory distress syndrome ( RDS ) , 60 % 70 % preterm infant &lt; 28 week ' gestation receive medical surgical therapy PDA [ 1 ] . Neonates left-to-right shunt ductus complicate RDS high respiratory failure , low survival rate , increase risk intracranial haemorrhage ( ICH ) , bronchopulmonary dysplasia ( BPD ) necrotizing enterocolitis ( NEC ) [ 2 ] . Therefore , closure PDA indicate significant left-to-right shunting occurs . Patent ductus arteriosus treat effectively intravenous indomethacin ibuprofen , lead permanent ductal closure 60 % 80 % infant [ 3-5 ] . However , preterm infant treat ibuprofen experience lower serum creatinine value , high urine output , less undesirable decreased organ blood flow vasoconstrictive adverse effect indomethacin-treated patient [ 4 ] . Recently , Sperandio et al . report high-doses indomethacin ( 1 mg/kg : fivefold usual dose ) safe effective closing PDA 98.5 % infant gestational age &lt; 33 week , demonstrated closure rate PDA relate cumulative dose give indomethacin [ 6 ] . Moreover , Desfrere et al . demonstrate currently recommend dose regimen ibuprofen ( 10-5-5 mg/kg/day ) associate low estimate probability ( 30.6 % ) closing PDA infant high-dose regimen ( 20-10-10 mg/kg/day ) might associate great , although unsatisfactory , probability ( 54.8 % ) closing PDA , without relevant side affect [ 7 ] . Furthermore , Hirt et al. , base pharmacokinetic finding , propose increase dose regimen ibuprofen postnatal period 10-5-5 mg/kg/day preterm infant &lt; 70 h age 14-7-7 mg/kg/day infant 70-108 h age 18-9-9 mg/kg/day infant 108-180 h age [ 8 ] . These study [ 6-8 ] suggest failure pharmacologic PDA closure might due inadequacy standard dose regimen large interindividual pharmacokinetics pharmacodynamic variation premature infant treatment PDA [ 9,10 ] . The investigator hypothesize early treatment PDA ibuprofen dose high actually recommend might increase closure rate preterm infant gestational age &lt; 29 week without increase occurrence associate adverse effect . To assess hypothesis investigator plan multicenter randomize control study compare effectiveness current ibuprofen regimen high-dose regimen close PDA . MATERIAL AND METHODS Patients Four tertiary neonatal intensive care unit participate trial ( Careggi University Hospital Florence , Sant'Anna University Hospital Turin , Regional Hospital Bozen , IRCCS Ospedale Maggiore Policlinico Milan ) . The study approve medical ethic committee center . Neonates enrolled write informed consent obtain parent . The criteria enrolment gestational age &lt; 29 week ; echocardiographic evidence significant PDA ; age 12 24 hour ; RDS necessitate respiratory support . Exclusion criterion major congenital anomaly ; life-threatening infection hydrops fetalis ; pulmonary hypertension ; death conclusion first course ibuprofen ; urine output 1 ml per kilogram body weight per hour precede 12 hour ( exception first dose ) ; serum creatinine concentration &gt; 1.5 mg/dL ( 129 μmol per liter ) ; platelet count &lt; 50,000/mm3 ; tendency bleed , reveal hematuria , blood endotracheal aspirate , gastric aspirate , stool , ooze puncture site . Study design The infant unit randomly assign treatment group mean card seal opaque envelope . Each infant receive three dos intravenous ibuprofen ( Pedea , Orphan Europe , Paris , France ) either accord standard regimen : initial dose 10 mg/kg , follow two dos 5 mg/kg , 24 48 hour ; high-dose regimen : initial dose 20 mg/kg , follow two dos 10 mg/kg , 24 48 hour . The treatment start 12 24 hour age medication infuse continuously period 15 minute . When ductus arteriosus still patent randomly assign treatment patient either group second course ibuprofen high-dose ( 20-10-10 mg/kg/day ) give nonrandomized treatment , start 24 hour last dose first course . If contraindication second pharmacologic treatment , therapy also fail promote ductal closure , subsequent pharmacological and/or surgical treatment PDA discretion center . The plasma ibuprofen concentration measure blood sample obtain 15 minute first dose ibuprofen 24 hour last dose 6 use high-pressure liquid chromatography ( HPLC ) , previously describe [ 11 ] . Echocardiography The first heart ultrasound examination perform 12 24 hour age ascertain normality cardiac anatomy , rule possibility congenital heart disease `` ductus dependent '' pulmonary systemic blood flow pulmonary hypertension , evaluate PDA . The diagnosis hemodynamically significant PDA require treatment make echocardiographic demonstration ductal left- to-right shunt , leave atrium aortic root ratio &gt; 1.3 ductal size &gt; 1.5 mm 12 . In enrolled patient echocardiography repeat dose ibuprofen ( 12-24 hour last dose assign treatment ) 7+1 , 15+2 , 30+2 day life detect possible re-opening PDA . All echocardiographic study perform physician unaware infant ' treatment assignment . Fluid intake guide body weight , serum sodium concentration serum osmolality . Daily fluid intake start 70-80 ml per kilogram increase 10-20 ml/kg/day 150 mL/kg end first week life . For treatment RDS , infant receive oxygen-therapy , respiratory support ( nasal continuous positive pressure , patient-triggered ventilation , high frequency oscillatory ventilation ) , rescue surfactant treatment ( Curosurf , Chiesi Farmaceutici Spa , Parma , Italy : first dose : 200 mg/kg ; follow dose : 100 mg/kg ) . Gestational age , birth weight , sex , type delivery , antenatal steroid treatment main maternal pregnancy pathology ( preterm non-induced labor , hypertensive disorder , premature rupture membrane , abruptio placenta , intrauterine growth restriction ) , high FIO2 mean airway pressure ( MAP ) value , type duration respiratory support , need surfactant ; daily fluid intake 1st week life , need dopmine/dobutamine plasma hypotension record infant . Serum creatinine dose 1 , 3 , 7 day life , daily urine output measure collection adhesive urine bag 1st week life . Oliguria define urine output &lt; 1 ml/kg/h 24-hour collection period . Moreover , platelet count measure 1 , 3 , 7 day life bleed disorder ( reveal hematuria , blood endotracheal aspirate , gastric aspirate , stool , ooze puncture site ) record 1st week life . For infant report : occurrence ICH ICH periventricular hemorrhage ( PVL ) [ 13,14 ] , BPD [ 15 ] , retinopathy prematurity ( ROP ) [ 16 ] , NEC [ 17 ] , sepsis [ 18 ] , mortality duration hospitalization . Statistical analysis The primary endpoint study evaluate successful rate closing PDA use ibuprofen . The investigator consider ibuprofen failure lack PDA closure end first course ibuprofen standard high-dose regimen group . On basis data agreement data literature 3-5 , investigator assume failure rate 25 % group treat standard ibuprofen regimen . Thus , detect statistically significant decrease failure rate 20 % ( 5 % ) group treat high ibuprofen regimen , investigator calculate sample size least 34 infant group necessary power 0.80 α=0.05 . Clinical characteristic two group describe mean value standard deviation , median value range , rate percentage . The t-test , Wilcoxon rank-sum test , Fisher 's exact test use compare continuous normally distribute data , nonparametric continuous data , categorical data , respectively . Secondary endpoint evaluation effectiveness high-dose ibuprofen course closing PDA refractory first ibuprofen course ; possible association dose regimen , occurrence adverse effect , ibuprofen plasma level ; comparison incidence ICH , PVL , ROP , NEC , BPD , sepsis , death hospital stay duration two group . Multiple logistic regression perform assess influence predictive factor rate PDA 1st ibuprofen course ; factor investigator analyze gestational age , sex , birth weight , use nonuse antenatal glucocorticoid , high FIO2 MAP value , assignment standard high-dose ibuprofen regimen group . Effect estimate express relative risk ( RR ) profile likelihood-based 95 % confidence limit . REFERENCES 1 . Clyman RI . N Engl J Med 2000 ; 343:728-30 2 . Hamrick SE et al . Pediatrics 2010 ; 125:1020-1030 . 3 . Itabashi K et al . J Pediatr 2003 ; 143:203-207 . 4 . Thomas RL et al . Eur J Pediatr 2005 ; 164:135-40 . 5 . Gournay V et al . Lancet . 2004 ; 364:1939-44 . 6 . Sperandio M et al . Pediatrics 2005 ; 116:1361-6 . 7 . Desfrere L etal . J Clin Pharm Ther 2005 ; 30:121-32 . 8 . Hirt D et al . Br J Clin Pharmacol 2008 ; 65:629-36 . 9 . Van Overmeire B et al . Clin Pharmacol Ther 2001 ; 70:336-43 . 10 . Seybert HP et al . Eur J Pediatr 1983 ; 141:71-6 . 11 . Rey E et al . British Journal Clinical Pharmacology 1994 ; 38:373-5 . 12 . Varvarigou A et al . JAMA 1996 ; 275:539-44 . 13 . Papile LS et al . J Pediatr 1978 ; 92 :529-34 . 14 . De Vries LS et al . Beha Brain Res 1992 ; 49:1-6 . 15 . Ehrenkranz RA et al . Pediatrics 2005 ; 116:1353-60 . 16 . Committee Classification Retinopathy Prematurity . Arch Ophthalmol 1984 ; 102:1130-4 . 17 . Bell MJ et al.Ann Surg 1978 ; 187:1-12 . 18 . American Academy Pediatric 's Committee drug , Committee fetus newborn Committee Infectious Diseases . Pediatrics 1980 ; 65:1047-53 .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Gestational age &lt; 29 week ; echocardiographic evidence significant PDA ; age 12 24 hour ; RDS necessitate respiratory support . Major congenital anomaly ; lifethreatening infection hydrops fetalis ; pulmonary hypertension ; death conclusion first course ibuprofen ; urine output 1 ml per kilogram body weight per hour precede 12 hour ( exception first dose ) ; serum creatinine concentration &gt; 1.5 mg/dL ( 129 μmol per liter ) ; platelet count &lt; 50,000/mm3 ; tendency bleed , reveal hematuria , blood endotracheal aspirate , gastric aspirate , stool , ooze puncture site .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Patent ductus arteriosus , ibuprofen , preterm infant</keyword>
</DOC>